Aspen acquires Sigma’s pharmaceutical business for R6,1 billion

Johannesburg. Aspen (APN), South Africa’s leading pharm… 继续阅读Aspen acquires Sigma’s pharmaceutical business for R6,1 billion

Aspen ARV tender bid is successful

Aspen ARV tender bid is successfulFollowing the announc… 继续阅读Aspen ARV tender bid is successful

Aspen’s CSI programmes provide increased ARV access to mothers and infants

Aspen’s CSI programmes provide increased ARV access to … 继续阅读Aspen’s CSI programmes provide increased ARV access to mothers and infants

Aspen’s Revenue increases by 20% to exceed R10 billion

Johannesburg – JSE Ltd listed Aspen Pharmacare Ho… 继续阅读Aspen’s Revenue increases by 20% to exceed R10 billion

Aspen Trading Update

By : Shauneen Beukes APN – Aspen Pharmacare Holdi… 继续阅读Aspen Trading Update

Acquisition of Sigma Pharmaceuticals Limited by Aspen

By : Shauneen Beukes ASPEN PHARMACARE HOLDINGS LIMITED … 继续阅读Acquisition of Sigma Pharmaceuticals Limited by Aspen

Aspen Sigma SENS Cautionary Renewal

Aspen Pharmacare Holdings Limited (Incorporated in the … 继续阅读Aspen Sigma SENS Cautionary Renewal

Aspen and Strides restructure Oncology arrangements

Aspen Pharmacare Holdings Limited (“Aspen”), listed on … 继续阅读Aspen and Strides restructure Oncology arrangements

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.